TrialJournal of diabetes investigation2018

Safety, tolerability and efficacy of lixisenatide as monotherapy in Japanese patients with type 2 diabetes mellitus: An open-label, multicenter study.

Yutaka Seino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.